Expert Perspective: Hematologic Malignancies and Vasculitis

Area of Science:

• Rheumatology and Hematology/Oncology
• Rare autoimmune and hematologic diseases

Background:

• Systemic vasculitis involves blood vessel inflammation, potentially triggered by malignancy.
• Hematologic malignancies are recognized causes of vasculitis, termed vasculitis with concomitant hematological malignancy (VCHM).
• VCHM presents diagnostic and treatment challenges due to refractory disease and comorbidities.

Purpose of the Study:

• To outline a collaborative approach to diagnosing and managing VCHM.
• To highlight the complexities of VCHM, particularly in the context of myeloid neoplasia.
• To inform rheumatologists about this evolving field and its management.

Main Methods:

• Review of existing literature on VCHM.
• Discussion of a collaborative diagnostic and management strategy between rheumatology and hematology/oncology.
• Focus on myeloid neoplasia as a model, with limited discussion of lymphoid associations.

Main Results:

• VCHM requires specialized, multidisciplinary care.
• Myeloid neoplasia serves as a relevant model for understanding VCHM.
• Increased molecular diagnostics in hematology necessitate rheumatologist awareness.

Conclusions:

• VCHM is a complex condition requiring integrated care from rheumatology and hematology/oncology.
• Rheumatologists must be aware of VCHM's diagnostic and therapeutic complexities.
• Further research is needed to refine management strategies for VCHM.